Skip to main content
HRES 95 114th Congress House

Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a…

Official title: Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment… Show full official titleShow less

Official title: Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.

Introduced: April 23, 2015 Introduced by: Vargas, Juan Democratic · California See on congress.gov
Health Advanced technology and technological innovationsBiological and life sciencesDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulation
More subjectsShow fewer subjects
Executive agency funding and structureFood and Drug Administration (FDA)Health programs administration and fundingHealth technology, devices, suppliesMedical researchResearch administration and fundingResearch and development
Sign in to write a letter Sign in to watch
This resolution expired with the 114th Congress
It was not agreed to before the 114th Congress (2015–2016) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Agreed to (House)
Feb 6, 2015
Referred to the Subcommittee on Health.
Feb 5, 2015
Referred to the House Committee on Energy and Commerce.
Feb 5, 2015
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 6, 2015

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Recognizes: the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and the ways those challenges can be addressed.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1
D
Peters, Scott H.
California · Apr 23, 2015
Cite this page click to expand
APA
U.S. Congress. (2026). H. Res. 95: Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.. 114th Congress. Open America. https://openamerica.io/bill/114-HRES-95/
MLA
"H. Res. 95: Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HRES-95/.
Bluebook (legal)
H. Res. 95, 114th Cong. (2026), https://openamerica.io/bill/114-HRES-95/.
Markdown link
[H. Res. 95: Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.](https://openamerica.io/bill/114-HRES-95/)
Report a problem